Abstract

The Sanford-Burnham Medical Research Institute has taken steps to position itself more like a disease-focused biotech than a not-for-profit research organization and now can build on the idea with two new partners: Johnson & Johnson and Takeda.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call